What Changed at Aignostics

Every material change AI Health Index has tracked at Aignostics: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Impact
Type
1 entry
Showing changes for Aignostics only.Show the full log

September 2026

A
Aignostics
Sep 12, 2026
MediumPartially Verified
Product / capability

Aignostics released PathoSearch in early access, a visual search engine for pathology: from a screenshot of a region of interest on an H and E slide it retrieves morphologically similar, diagnosed reference cases so a pathologist can build a differential in minutes. Search runs on embeddings from Atlas 2, Aignostics' pathology foundation model co developed with Mayo Clinic, against a curated multi centre reference set of more than 310,000 whole slide images from over 35,000 cases spanning more than 300 diagnostic entities across 27 organs, covering thoracic, digestive, soft tissue and bone, female genital, and urinary and male genital cancers at launch. The first integration is live inside Techcyte's Fusion AP slide viewer, where a selected region is passed to PathoSearch without export or upload. PathoSearch is free during early access, by waitlist, and is labelled research use only, not for diagnostic procedures.

Our read

Rare and complex cases are where a pathologist reaches for a textbook or a paid consult, and image similarity search against a diagnosed reference set is a plausible replacement for the first of those. The research use only label is the operative constraint: this cannot be part of a signed out diagnosis today, and a lab evaluating it should treat the Fusion AP integration as the way to try it inside the workflow rather than as a clinical deployment.

Related axis: AI CentralityVendor announcementView source